Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Reduced graphene oxide induces transient blood-brain barrier opening: an in vivo study

Full text
Author(s):
Padilha Mendonca, Monique Culturato [1, 2] ; Soares, Edilene Siqueira [2] ; de Jesus, Marcelo Bispo [2] ; Ceragioli, Helder Jose [3] ; Ferreira, Monica Siqueira [4] ; Catharino, Rodrigo Ramos [4] ; da Cruz-Hoefling, Maria Alice [1, 2]
Total Authors: 7
Affiliation:
[1] Univ Estadual Campinas, Dept Pharmacol, Fac Med Sci, Campinas, SP - Brazil
[2] Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP - Brazil
[3] Univ Estadual Campinas, Fac Elect & Comp Engn, Dept Semicond Instruments & Photon, Campinas, SP - Brazil
[4] Univ Estadual Campinas, Dept Med & Expt Surg, Fac Med Sci, Campinas, SP - Brazil
Total Affiliations: 4
Document type: Journal article
Source: JOURNAL OF NANOBIOTECHNOLOGY; v. 13, OCT 30 2015.
Web of Science Citations: 31
Abstract

Background: The blood-brain barrier (BBB) is a complex physical and functional barrier protecting the central nervous system from physical and chemical insults. Nevertheless, it also constitutes a barrier against therapeutics for treating neurological disorders. In this context, nanomaterial-based therapy provides a potential alternative for overcoming this problem. Graphene family has attracted significant interest in nanomedicine because their unique physicochemical properties make them amenable to applications in drug/gene delivery and neural interface. Results: In this study, reduced graphene oxide (rGO) systemically-injected was found mainly located in the thalamus and hippocampus of rats. The entry of rGO involved a transitory decrease in the BBB paracellular tightness, as demonstrated at anatomical (Evans blue dye infusion), subcellular (transmission electron microscopy) and molecular (junctional protein expression) levels. Additionally, we examined the usefulness of matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) as a new imaging method for detecting the temporal distribution of nanomaterials throughout the brain. Conclusions: rGO was able to be detected and monitored in the brain over time provided by a novel application for MALDI-MSI and could be a useful tool for treating a variety of brain disorders that are normally unresponsive to conventional treatment because of BBB impermeability. (AU)

FAPESP's process: 11/50400-0 - Mitochondrial energy metabolism, redox state and functionality in cell death and cardiometabolic and neurodegenerative disorders
Grantee:Aníbal Eugênio Vercesi
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 12/24782-5 - Graphene oxide and central nervous system: evaluation of effects on blood brain barrier and nanotoxicological profile
Grantee:Monique Culturato Padilha Mendonça
Support Opportunities: Scholarships in Brazil - Doctorate